Background: It is unclear whether patients with adult congenital heart disease (ACHD) should be considered as an increased risk population with poor outcomes when suffering from COVID-19.
Aims: This study aimed to collect clinical outcome data and to identify risk factors of a complicated course of COVID-19 among ACHD patients.
Methods: Among all outpatients who came to medical attention via telemedicine or direct physician contact at our institution between September 1, 2020 and March 31, 2021, we included all with a COVID-19 diagnosis.